P58.3
Neonatal jaundice due to polycythemia
Clinical Classification Guidelines
Medical Intelligence & Overview
Neonatal jaundice due to polycythemia is a condition that affects newborn babies, leading to a yellowish coloration of the skin and eyes. This occurs when there is an excessive number of red blood cells, known as polycythemia, which causes an increase in bilirubin levels—the substance responsible for the yellow color. Recognizing and understanding this condition can help in ensuring appropriate medical care and management for affected newborns.
Causes & Symptoms
Clinical Causes: Overproduction of red blood cells by the baby’s bone marrow Delayed clearance of red blood cells after birth Maternal conditions, such as diabetes or placental insufficiency, leading to increased blood volume or red blood cell production in the fetus Genetic predispositions that influence red blood cell production Intrauterine hypoxia (oxygen deprivation during pregnancy) stimulating increased red blood cell production
Key Symptoms: Yellow discoloration of the skin and whites of the eyes (jaundice) Lethargy or decreased activity levels in the infant Poor feeding or difficulty feeding Swelling due to increased blood viscosity Respiratory distress in severe cases Dark-colored urine or pale stool
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a combination of clinical examination and laboratory tests. Healthcare providers will commonly perform:
Treatment Protocols: Treatment strategies aim to reduce bilirubin levels, manage blood viscosity, and address the underlying causes. Approaches can include:
Clinical Advice & FAQs
Billing Guidance
Is P58.3 a billable ICD-10 code?
Yes, P58.3 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report P58.3?
Clinical documentation must specify the nature of Neonatal jaundice due to polycythemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference